Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (191-200 of 427) with videos related to

Pageof 43
Sort By:
BMC Medical Research Methodology|December 28, 2024
Toward value-based care using cost mining: cost aggregation and visualization across the entire colorectal cancer patient pathwayMaura Leusder, Sven Relijveld, Derya Demirtas, et al.
ANZ Journal of Surgery|April 1, 2021
Positive lateral pelvic lymph nodes in low rectal cancer: should we change our practice now?Richard Gartrell, Michael K-Y Hong, Ali Baker, et al.
Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.
Internal Medicine Journal|June 6, 2022
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancerMatthew Loft, Jeremy Shapiro, Margaret Lee, et al.
Cancers|August 26, 2022
A Simultaneous Multiparametric <sup>18</sup>F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast CancerValeria Romeo, Panagiotis Kapetas, Paola Clauser, et al.
Internal Medicine Journal|October 11, 2020
Use and outcomes of chemotherapy for metastatic pancreatic cancer in AustraliaAmy Body, Rachel Wong, Jeremy Shapiro, et al.
Growth Factors (Chur, Switzerland)|March 29, 2021
Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancerSiavash Foroughi, Ryan A Hutchinson, Hui-Li Wong, et al.
Asia-Pacific Journal of Clinical Oncology|August 19, 2014
Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practiceSheau Wen Lok, Hui-Li Wong, Suzanne Kosmider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practiceSumitra Ananda, Kathryn M Field, Suzanne Kosmider, et al.
Cancers|June 24, 2022
Can <sup>18</sup>F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?Vetri Sudar Jayaprakasam, Peter Gibbs, Natalie Gangai, et al.
Pageof 43

Showing results (191-200 of 427) with videos related to

Sort By:
Pageof 43
BMC Medical Research Methodology|December 28, 2024
Toward value-based care using cost mining: cost aggregation and visualization across the entire colorectal cancer patient pathwayMaura Leusder, Sven Relijveld, Derya Demirtas, et al.
ANZ Journal of Surgery|April 1, 2021
Positive lateral pelvic lymph nodes in low rectal cancer: should we change our practice now?Richard Gartrell, Michael K-Y Hong, Ali Baker, et al.
Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.
Internal Medicine Journal|June 6, 2022
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancerMatthew Loft, Jeremy Shapiro, Margaret Lee, et al.
Cancers|August 26, 2022
A Simultaneous Multiparametric <sup>18</sup>F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast CancerValeria Romeo, Panagiotis Kapetas, Paola Clauser, et al.
Internal Medicine Journal|October 11, 2020
Use and outcomes of chemotherapy for metastatic pancreatic cancer in AustraliaAmy Body, Rachel Wong, Jeremy Shapiro, et al.
Growth Factors (Chur, Switzerland)|March 29, 2021
Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancerSiavash Foroughi, Ryan A Hutchinson, Hui-Li Wong, et al.
Asia-Pacific Journal of Clinical Oncology|August 19, 2014
Translation of clinical trial outcomes to metastatic colorectal cancer patients in community practiceSheau Wen Lok, Hui-Li Wong, Suzanne Kosmider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Patient age and comorbidity are major determinants of adjuvant chemotherapy use for stage III colon cancer in routine clinical practiceSumitra Ananda, Kathryn M Field, Suzanne Kosmider, et al.
Cancers|June 24, 2022
Can <sup>18</sup>F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?Vetri Sudar Jayaprakasam, Peter Gibbs, Natalie Gangai, et al.
Pageof 43